[ Price : $8.95]
FDA accepts a TG Therapeutics NDA for umbralisib, a once-daily, oral, dual inhibitor of PI3K-delta and CK1-epsilon for treating ce...[ Price : $8.95]
Federal Register notice: FDA announces a10/30 public workshop entitled New Drugs Regulatory Program Modernization: Implementation ...[ Price : $8.95]
FDA makes available a draft guidance entitled Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment.[ Price : $8.95]
FDA makes available a draft guidance entitled Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment.[ Price : $8.95]
FDA approves NS Pharmas Viltepso to treat Duchenne muscular dystrophy patients with a specific confirmed gene mutation.[ Price : $8.95]
CDER researchers describe efforts to develop immunomodulatory therapies for Covid-19.[ Price : $8.95]
FDA issues a guidance to help sponsors develop drugs to treat breast cancer in males.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection entitled Medical Devices; Humanitarian Use Devices (HUD) ...